Hydroxocobalamin-Induced Oxalate Nephropathy in a Patient With Smoke Inhalation
- PMID: 34386674
- PMCID: PMC8343717
- DOI: 10.1016/j.ekir.2021.05.019
Hydroxocobalamin-Induced Oxalate Nephropathy in a Patient With Smoke Inhalation
Figures
References
-
- Legrand M., Michel T., Daudon M. Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients. Intensive Care Med. 2016;42:1080–1081. - PubMed
-
- Abdelmalek J., Thornton S., Nizar J. Successful use of continuous renal replacement therapy after hydroxocobalamin administration. Dial Transplant. 2011;40(9):415–417.
Publication types
LinkOut - more resources
Full Text Sources
